UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 7, 2023
Accession Number: 0001493152-23-031478
Submission Type: POS AM
CIK: 0001460702
Company Name: Qualigen Therapeutics, Inc.
File Number: 333-269088